Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke?

Journal article

Alteplase for acute ischemic stroke may be the first stroke intervention to have a significant public health impact. In February 1999, this therapy was conditionally licensed in Canada for acute ischemic stroke within three hours of symptom onset. However, considerable controversy exists regarding its safety, its wider applicability outside clinical trials, and its ultimate availability. In this article we review the thrombolytic literature, attempt to answer many of the concerns, provide new...

Expand abstract

Authors: Barber, P; Hill, MD; Demchuk, A; Buchan, A

• Publication status: Published
• Journal: Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
• Volume: 27
• Issue: 4
• Pages: 283-287
• Publication date: 2000-11-01
• ISSN: 0317-1671
• Language: English
• Keywords: Humans; Stroke; Canada; Cerebral Hemorrhage; Forecasting; Thrombolytic Therapy; Fibrinolytic Agents; Brain Ischemia; Clinical Trials as Topic; Practice Guidelines as Topic; Tissue Plasminogen Activator